Luminor Medical Technologies
Winnipeg · Founded 1998
About Luminor Medical Technologies
Luminor Medical Technologies is a medical diagnostic company, focuses on acquiring, developing, and commercializing non-invasive tests for unmet clinical needs in Canada. The company’s products and services include PREVU Skin Cholesterol Test, a non-invasive test that measures cholesterol in the skin tissues to assess risk of coronary artery disease or heart disease; PSP94, an enzyme linked immunosorbent assay for urine specimens; and testing services. Its diagnostic programs under development comprise cardiovascular disease, preeclampsia, prostate cancer, colorectal cancer, pancreatic cancer, and gastric cancer programs. The company has a partnership agreement with Alere, Inc. for the development of tests for preeclampsia biomarkers.
Company Facts
- Founded: 1998
- Legal name: Rise Life Science Corp
- Operating status: IPO
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.4M
- Funding stage: IPO
- Last round: Post-IPO Debt (Oct 2016)
- Website: luminormedical.com
- Phone: 204-453-1370
Canonical: https://fsome.com/organization/luminor-medical-technologies-8242401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.